Néphrologie & Thérapeutique 2024/2 Volume 20
Article de revue

Argumentaire justifiant le dosage des marqueurs biochimiques de routine en hémodialyse

Pages 143 à 146

Citer cet article

  • NODIMAR, Céline
  • et CHAUVEAU, Philippe,
2024. Argumentaire justifiant le dosage des marqueurs biochimiques de routine en hémodialyse. Néphrologie & Thérapeutique, 2024/2 Volume 20, p.143-146. DOI : 10.1684/ndt.2024.74. URL : https://stm.cairn.info/revue-nephrologie-et-therapeutique-2024-2-page-143?lang=fr.
  • Nodimar, Céline.
  • et al.
« Argumentaire justifiant le dosage des marqueurs biochimiques de routine en hémodialyse ». Néphrologie & Thérapeutique, 2024/2 Volume 20, 2024. p.143-146. CAIRN.INFO, stm.cairn.info/revue-nephrologie-et-therapeutique-2024-2-page-143?lang=fr.
  • Nodimar, C.
  • et Chauveau, P.
(2024). Argumentaire justifiant le dosage des marqueurs biochimiques de routine en hémodialyse. Néphrologie & Thérapeutique, 20(2), 143-146. https://doi.org/10.1684/ndt.2024.74.

https://doi.org/10.1684/ndt.2024.74

Article
Bibliographie
Auteur(e)s
Illustrations
Sur un sujet proche
  • 1 • Canaud B, Fouque D. Recommandations européennes de bonnes pratiques (EBPG) en hémodialyse. Deuxième vague. Nephrol Ther 2008 ; 4 : 115-24.
  • 2 • National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015 ; 66 : 884-930.
  • 3 • Jindal K, Chan CT, Deziel C, et al. Hemodialysis clinical practice guidelines for the Canadian society of nephrology. J Am Soc Nephrol 2006 ; 17 (3 suppl. 1) : S1-27.
  • 4 • Mactier R, Hoenich N, Breen C, et al. Renal association clinical practice guideline on haemodialysis. Nephron Clin Pract 2011 ; 118 (suppl. 1) : c241-86.
  • 5 • Watanabe Y, Kawanishi H, Suzuki K, et al. Japanese societey for dialysis therapy guideline for maintenance hemodialysis : Hemodialysis prescriptions. Ther Apher Dial 2015 ; 19 : 67-92.
  • 6 • Alp Ikizler T, Jerrilynn D, Burrowes, et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis 2020 ; 76 : S1-107.
  • 7 • Ye X, Kooman JP, van der Sande FM, et al. Increased mortality associated with higher pre-dialysis serum sodium variability: results of the International MONitoring Dialysis Outcome Initiative. Am J Nephrol 2019 ; 49 : 1-10.
  • 8 • Hecking M, Karaboyas A, Saran R, et al. Predialysis serum sodium level, dialysate sodium, and mortality in maintenance hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2012 : 59 : 238-48.
  • 9 • Rhee CM, Ayus JC, Kalantar-Zadeh K. Hyponatremia in the dialysis population. Kidney Int Rep 2019 ; 4 : 769-80.
  • 10 • Peixoto AJ, Santos SFF. How should the predialysis plasma sodium level be interpreted in hemodialysis patients? Semin Dial 2011 ; 24 : 409-11.
  • 11 • Munoz Mendoza J, Arramreddy R, Schiller B. Dialysate sodium : choosing the optimal hemodialysis bath. Am J Kidney Dis 2015 ; 66 : 710-20.
  • 12 • Fujisaki K, Joki N, Tanaka S, et al. Pre-dialysis hyponatremia and change in serum sodium concentration during a dialysis session are significant predictors of mortality in patients undergoing hemodialysis. Kidney Int Rep 2020 ; 6 : 342-50.
  • 13 • Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007 ; 2 : 999-1007.
  • 14 • Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G. Characteristics of sudden death in hemodialysis kidney international. Kidney Int 2006 ; 69 : 2268-73.
  • 15 • Ohnishi T, Kimachi M, Fukuma S, et al. Postdialysis hypokalemia and all-cause mortality in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol 2019 ; 14 : 873-81.
  • 16 • Karaboyas A, Zee J, Brunelli SM, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2017 ; 69 : 266-77.
  • 17 • Ashby D, Borman N, Burton J, et al. Renal Association Clinical Practice Guideline on haemodialysis. BMC Nephrol 2019 ; 20 : 379.
  • 18 • Pun PH, Middleton JP. Dialysate potassium, dialysate magnesium, and hemodialysis risk. J Am Soc Nephrol 2017 ; 28 : 3441-51.
  • 19 • Hung AM, Hakim RM. Dialysate and serum potassium in hemodialysis. Am J Kidney Dis 2015 ; 66 : 125-32.
  • 20 • Bleyer AJ, Hartman J, Brannon PC, et al. Characteristics of sudden death in hemodialysis patients. Kidney Int 2006 ; 69 : 2268-73.
  • 21 • Woodell Tb, Rifkin D, Ellison DH, Negoianu D, Weiss JW. Serum bicarbonate as a surrogate for pH in hemodialysis: a pilot study. Kidney Med 2020 ; 2 : 42-8.
  • 22 • Abramowitz MK. Bicarbonate balance and prescription in ESRD. J Am Soc Nephrol 2017 ; 28 : 726-34.
  • 23 • Kalani L. Raphael Metabolic acidosis in CKD : Core Curriculum 2019. Am J Kidney Dis 2019 ; 74 : 263-75.
  • 24 • Jeffrey A Kraut, Madias N. Adverse effects of the metabolic acidosis of chronic kidney disease. Adv Chronic Kidney Dis 2017 ; 24 : 289-97.
  • 25 • Lefevre A, de Vernejoul M, Gueris J, Goldfarb B, Graulet AM, Morieux C. Optimal correction of acidosis changes progression of dialysis osteodystrophy. Kidney Int 1989 ; 36 : 1112-8.
  • 26 • Melamed ML, Raphael KL. Metabolic acidosis in CKD: a review of recent findings. Kidney Med 2021 ; 3 : 267-77.
  • 27 • Wu D, Shinaberger C, Regidor DL, et al. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol 2006 ; 1 : 70-8.
  • 28 • Chauveau P, Rigothier C, Combe C, et al. Higher serum bicarbonate in dialysis patients is protective. Nephrol Dial Transplant 2016 ; 31 : 1w226-9.
  • 29 • Bezerra Calvalcanti Sette L, Pessoa de Almeida Lopes E. Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review. Clinics 2014 ; 69 : 271-8.
  • 30 • Saab S, Brezina M, Gitnick G, Martin P, Yee HF Jr. Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 2001 ; 38 : 91-7.
  • 31 • Saab S, Martin P, Brezina M, Gitnick G, Yee HF Jr. Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. Am J Kidney Dis 2001 ; 37 : 308-15.
  • 32 • Couchoud C, Jager KJ, Tomson C, et al. Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. Nephrol Dial Transplant 2009 ; 24 : 1267-74.
  • 33 • Chidiac C, Chelala, Nassar D, et al. Routine laboratory testing in hemodialysis: how frequently is it needed. BMC Nephrol 2022 ; 23 : 344.
  • 34 • Thomas A, Silver S, Perl J, et al. The frequency of routine blood sampling and patient outcomes among maintenance hemodialysis recipients. Am J Kidney Dis 2020 ; 75 : 471-9.